(UPDATED) European Medicines Agency confirms positive benefit-risk balance of somatropin-containing medicines (EMA press release, 21 December 2011)

22 Dec 2011


The European Medicines Agency has updated a press release which was issued to announce the conclusion of its review into the benefit-risk ratio of somatropin-containing medicines. The update concerns details of the studies mentioned in the press release.

Full press release


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story